CTOs on the Move

lensgen

www.lensgen.com

 
LensGen™ is an ophthalmic medical device company developing an accommodating intraocular lens (AIOL) based solution to treat presbyopia and/or cataracts.
  • Number of Employees: 0-25
  • Annual Revenue: $0-1 Million
  • www.lensgen.com
  • 6 Jenner Suite 230
    Irvine, CA USA 92618
  • Phone: 949.420.0814

Executives

Name Title Contact Details

Funding

lensgen raised $11M on 07/17/2018
lensgen raised $10M on 08/20/2020

Similar Companies

Trilogy International Inc

Trilogy International Inc is a Palm City, FL-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

legend health staffing

legend health staffing is a Houston, TX-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Landauer

Landauer is committed to providing unrivaled radiation monitoring service and to ongoing discovery for improving radiation safety Landauer is the global leader in radiation science and services. We provide tools and support to organizations with potential exposure to ionizing radiation, helping them achieve their radiation safety goals. Our proprietary, state-of-the-art optically stimulated luminescence (OSL) technology enables the most precise measurements possible for occupational radiation monitoring and environmental monitoring and a full range of specialized applications including machine quality assurance and patient radiation monitoring. We back our advanced technology with the most flexible dosimetry programs and best customer service the industry has to offer. While technology continues to advance, one thing is certain with each innovation we must also focus on identifying and mitigating any potential risks related to the benefits. As the first organization to recognize and address radiation risks, and with a sustained history of innovation and dedication unequaled in the industry, LANDAUER is uniquely poised to lead this quest for improved personal and public health and safety across the globe.

Second Sight

Second Sight ® Medical Products, Inc., located in Sylmar, California, was founded in 1998 to create a retinal prosthesis to provide sight to patients blinded from outer retinal degenerations, such as Retinitis Pigmentosa.

Medacta USA

Medacta International is a Swiss company developing, manufacturing and distributing orthopaedic and neurosurgical medical devices worldwide. Founded in 1999 with a vision to create a better patient experience for people needing joint and spine treatment, Medacta specializes in highly innovative minimally-invasive, personalized approaches designed to bring renewed hope and optimism to patients. Medacta is a recognized leader in Hip Replacement with its proprietary AMIS® (Anterior Minimally Invasive Surgery) product offerings and in Knee Replacement via MyKnee® Patient Matched 3-D printing technology. At the 2014 North American Spine Society (NASS) Annual Meeting, Medacta`s new MySpine® Patient Matched product was awarded "Best New Technology - Posterior Thoracolumbar Spine Treatments".